Company Overview of OccuRx Pty. Ltd.
OccuRx Pty. Ltd., a biopharmaceutical company, engages in the development of therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis and inflammation. It has a library of chemical compounds with potent anti-inflammatory and anti-fibrotic properties to treat diabetic retinopathy and other fibrotic diseases of the retina. The company was incorporated in 2013 and is based in Melbourne, Australia.
278 Collins Street
Melbourne, VIC 3000
Founded in 2013
61 3 9657 0704
61 3 9657 0777
Key Executives for OccuRx Pty. Ltd.
OccuRx Pty. Ltd. Key Developments
Similar Private Companies By Industry
|AbRegen Pty Ltd.||Asia|
|Advanced Wound Care Pty Ltd.||Asia|
|Agriliance Pty Ltd.||Asia|
|AION Diagnostics Limited||Asia|
|Aquaceutics Pty Ltd||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact OccuRx Pty. Ltd., please visit www.occurx.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.